Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.

PubWeight™: 1.38^‹?› | Rank: Top 10%

🔗 View Article (PMID 28395880)

Published in Lancet Oncol on April 07, 2017

Authors

Smita S Chandran¹, Robert P T Somerville¹, James C Yang¹, Richard M Sherry¹, Christopher A Klebanoff¹, Stephanie L Goff¹, John R Wunderlich¹, David N Danforth¹, Daniel Zlott¹, Biman C Paria¹, Arvind C Sabesan¹, Abhishek K Srivastava¹, Liqiang Xi², Trinh H Pham², Mark Raffeld², Donald E White¹, Mary Ann Toomey¹, Steven A Rosenberg¹, Udai S Kammula³

Author Affiliations

1: Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
2: Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
3: Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: udai_kammula@nih.gov.

Associated clinical trials:

Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma (PULSE-UM) | NCT05047276

Articles citing this ↘

Immunotherapy: Cul-TIL-vating uveal melanoma regression. Nat Rev Clin Oncol (2017) 0.75

Articles by these authors ⇆

Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients. Ann Surg Oncol (2017) 0.79

Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer. Breast Cancer (Auckl) (2016) 0.77

An Improved Breast Epithelial Sampling Method for Molecular Profiling and Biomarker Analysis in Women at Risk for Breast Cancer. Breast Cancer (Auckl) (2015) 0.76